Scientists are urgently seeking fluid biomarkers for frontotemporal dementia, the most common dementing illness among 40- and ...

In related news, other scientists recently reported that phospho-tau isoforms in the CSF mirror protofibrillar forms of tau, ...

Seminar from Dr. Jinjun Shi from Brigham and Women's Hospital and Harvard Medical School to highlight study of proteomic perturbations resulting from a novel approach to cancer therapy revealed using ...

Your brain’s natural rinse cycle flows while you sleep. A new study suggests certain medications interfere with that ...

Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

In a case report published in the New England Journal of Medicine, doctors explain how they figured out the source of her ...

The factor that tips you over the edge from being at risk for a disease to actually developing the disease is not always ...

Researchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing ...

Up to half of all people living with Alzheimer's Disease in Ireland remain undiagnosed. Now, a new blood test may have the ...

Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

A new blood test may have the potential to transform Alzheimer’s disease diagnosis, patient care, early interventions and ...